Sign Up to like & get
recommendations!
0
Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.17676
Abstract: Key Points Question Is paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) safe and associated with equivalent outcomes as cisplatin-based HIPEC in the treatment of advanced ovarian cancer after interval cytoreductive surgery? Findings In this cohort study with…
read more here.
Keywords:
paclitaxel based;
based hipec;
advanced ovarian;
ovarian cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.4_suppl.373
Abstract: 373 Background: Peritoneal metastasis (PM) occurs in about 5% - 20% of patients with gastric cancer (GC) at the time of diagnosis, and prognosis remains poor with limited treatment options. There are conflicting results on…
read more here.
Keywords:
paclitaxel based;
patients gastric;
analysis;
based regimens ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.38.4.4736
Abstract: Objective: To analyze the effects of carboplatin combined with paclitaxel-based intraperitoneal hyperthermic perfusion chemotherapy (IPCH) on serum levels of human epididymis protein 4 (HE4) and mitogen-dependent oncogene-1 (DJ-1) in patients with advanced recurrent ovarian cancer…
read more here.
Keywords:
cd3;
combined paclitaxel;
carboplatin combined;
patients advanced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancer Management and Research"
DOI: 10.2147/cmar.s508673
Abstract: Objective To evaluate the clinical efficacy of nab-paclitaxel based chemotherapy in the treatment of advanced epithelioid hemangioendothelioma (EHE). Methods Since March 2022, chemotherapy has been recommended for patients with advanced EHE characterized by large tumors…
read more here.
Keywords:
treatment;
paclitaxel based;
nab paclitaxel;
chemotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12371
Abstract: Background/Aim: In the CheckMate-141 trial regarding head and neck cancer (HNC), nivolumab conferred a survival benefit to patients. However, the best treatment sequence of chemotherapy and anti-PD-1/PD-L1 therapy in these cancers is unclear. Patients and…
read more here.
Keywords:
neck cancer;
based chemotherapy;
paclitaxel based;
head neck ... See more keywords